Literature DB >> 25668438

Patient information leaflets: friend or foe?

A Pines1.   

Abstract

Every registered medication has an information insert in its package. This patient leaflet provides information on the product, which includes clinical pharmacology, recommended dose, mode of administration, how supplied, and a large section contains warnings and contraindications, adverse reactions, and precautions. Most of the prescribers do not read the patient information leaflets and do not discuss it with the users, whereas some patients do read it thoroughly. This may create worries and uncertainties resulting in reduced compliance to treatment. With easy access of patients to information on drugs that they use, mainly through the electronic media, it is very important that the text and contents of these patient leaflets are simple to understand and readable. Although information from official health agencies is superior to net-based sources, the patient information leaflets should be improved and become more user-friendly and less frightening.

Entities:  

Keywords:  ESTROGEN; PACKAGE INSERT; PATIENT INFORMATION LEAFLET; PATIENT–DOCTOR COMMUNICATION

Mesh:

Substances:

Year:  2015        PMID: 25668438     DOI: 10.3109/13697137.2015.1007697

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  2 in total

1.  From Print to Screen: Regulatory Considerations to Adopting Innovative Approaches for Patient Information and Safety.

Authors:  Winona Rei R Bolislis; Charlie Mortazavi; Rossana Riccioni; Paul-Etienne Schaeffer; Thomas C Kühler
Journal:  Ther Innov Regul Sci       Date:  2019-12-09       Impact factor: 1.778

2.  Development of patient information leaflets for fixed, removable, and functional appliances for Arabic-speaking orthodontic patients.

Authors:  Yassir A Yassir; Ammar S Kadhum; Hayder F Saloom; Grant T McIntyre; David R Bearn
Journal:  Saudi Dent J       Date:  2019-12-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.